New Market Research Report: China Cervus and Cucumis Polypeptide Market, 2010-2019

According to statistics, the incidence of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. With the ageing population in China, over 60% of elder people aged above 60 suffer from osteoarthritis, says a study. Patients with osteoarthritis typically show reduced mobility and life quality caused by joint pain, malformation and joint dysfunction.
First developed by Gloria Pharmaceuticals Co., Ltd, cervus and cucumis polypeptide is a sterile water solution made of extracted bones of Cervus Nippon Temmick and the dry mature seeds of Cucumis melo L. And it works well in rheumatism, RA, early healing of fracture, osteoarthritis, pain in waist and lower extremities as well as wound recovery.
Cervus and cucumis polypeptide develops fast after entering China, annual sales value rising from less than CNY 10 million in 2006 to CNY 310 million in 2014 and CAGR during this period exceeding 50%. Currently, cervus and cucumis polypeptide in the Chinese market all come from the following three companies: Gloria Pharmaceuticals Co., Ltd, Heilongjiang Dilong Pharmaceutical Co., Ltd and Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Gloria Pharmaceuticals Co., Ltd has the largest market share of over 80% for sales value in 2014.
The ageing population in China keeps growing, people aged 60 and above amounting to 212.42 million and occupying 15.5% of the total population while people aged 65 and above amounting to 137.55 million and occupying 10.1% of the total population by the end of 2014. With the ageing population, the incidence of RA will continue to grow. Therefore the market size of cervus and cucumis polypeptide is expected to keep expanding in the next few years in China.

Full Report Details at
- http://www.fastmr.com/prod/1015922_china_cervus_cucumis.aspx?afid=301

Readers can get at least the following information from this report:

* market size of cervus and cucumis polypeptide in China
* competitive landscape of cervus and cucumis polypeptide in Chinese market
* price of cervus and cucumis polypeptide made by different enterprises in China
* market outlook of cervus and cucumis polypeptide in China

The author suggests the following groups of people purchase this report:

* manufacturers of RA drugs
* investors/ research institutions interested in Chinese medicine market
* any interest in the Chinese medicine market, please contact CRI for customized survey service

Companies Mentioned in this Report: Heilongjiang Dilong Pharmaceutical Co., Ltd, Heilongjiang Jiangshi Pharmaceutical Co., Ltd, Gloria Pharmaceuticals Co., Ltd

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Biologic Therapeutics Market 2014-2018
- Global Peptide Therapeutics Market 2014-2018
- Isogenica Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Versartis, Inc. (VSAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile